USFDA completes inspection at Strides Pharma Science’s Alathur facility

24 Jan 2020 Evaluate

US Food and Drug Administration (USFDA) has successful completed an inspection at Strides Pharma Science’s formulation facility at Alathur (Chennai) with Zero 483 observations. This is the second consecutive Zero 483 inspection for the site.

The current inspection was a Pre?Approval Inspection for sustained release class of drugs which is a new dosage format for the facility and is one of the focus areas for the company in the global markets. The facility recently completed a significant capacity expansion which will support the growth momentum for the US business.

Strides Pharma Science (Formerly Strides Shasun) is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world’s largest manufacturers of soft gelatin capsules.

Strides Pharma Scien Share Price

878.65 -7.00 (-0.79%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×